Glycerin

Product NDC: 46122-221
11-digit product format: 461220221
Labeler code: 46122
Product ID: 46122-221_4147d1ac-9ee0-6442-e063-6294a90a576f
Type: HUMAN OTC DRUG
Nonproprietary name: Glycerin
Dosage form: SUPPOSITORY
Route: RECTAL
Labeler: Amerisource Bergen/Good Neighbor Pharmacy
Application: M007
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 2013-09-12
Substance: GLYCERIN
Active strength: 2.1 g/1
Pharmacologic classes: Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 21 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	46122-221-63	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	46122-221-71	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	46122-221-63	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	46122-221-71	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	46122-221-63	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	46122-221-71	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	46122-221-63	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	46122-221-71	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	46122-221-71	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	46122-221-63	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	46122-221-71	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	46122-221-63	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	46122-221-71	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	46122-221-63	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Glycerin
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
GLYCERIN	2.1 g/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
PDC6A3C0OX	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
583084	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
e6a8914f-cfd9-4c72-abaa-22189bf0faef	Available on FDA.report

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
46122-221-63	2025-07-02	GNP Glycerin Supp.
46122-221-63	2025-07-02	GNP Glycerin Supp.
46122-221-71	2025-07-02	GNP Glycerin Supp.
46122-221-71	2025-07-02	GNP Glycerin Supp.
46122-221-63	2025-01-30	GNP Glycerin Supp.
46122-221-63	2025-01-30	GNP Glycerin Supp.
46122-221-71	2025-01-30	GNP Glycerin Supp.
46122-221-71	2025-01-30	GNP Glycerin Supp.

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
46122-221-63	Glycerin	25 in 1 JAR	SUPPOSITORY	25		11
46122-221-71	Glycerin	50 in 1 JAR	SUPPOSITORY	50		11

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
46122-221-63	EA - Each	46122-221	ef78bcd7-30bc-4df8-b7e5-bd3e8eb0978c	1	2013-10-17
46122-221-71	EA - Each	46122-221	12ac563a-74be-4ff3-8d4d-a32a1c803335	1	2013-10-17

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
46122-221	GLYCERIN (GLYCERIN) SUPPOSITORY [AMERISOURCE BERGEN/GOOD NEIGHBOR PHARMACY]	8	Current NDC, Legacy NDC, 2 package rows	20231209_e6a8914f-cfd9-4c72-abaa-22189bf0faef.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 33 of 42 · 833 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Stratuscare Glycerin Laxative Pediatric	GLYCERIN	Stratus Pharmaceuticals	6ae6d3c4-bb3b-4436-b76d-8654bf871e66	2024-11-01	Warnings	Exact identifier application number: M007
Rite Aid Fiber Therapy	METHYLCELLULOSE	RITE AID CORPORATION	e50cea80-c020-4b85-b61f-d053f11f479b	2024-10-30	Warnings	Exact identifier application number: M007
Rite Aid Fiber Caplets	CALCIUM POLYCARBOPHIL	RITE AID CORPORATION	06e46cb0-2928-479e-984d-2305fff995e0	2024-10-30	Warnings	Exact identifier application number: M007
Premier Value Orange Flavor	PSYLLIUM HUSK	PHARMACY VALUE ALLIANCE, LLC	2d580965-2bef-46ee-8532-fbe34330a4b4	2024-10-28	Warnings	Exact identifier application number: M007
Premier Value Fiber Therapy	METHYLCELLULOSE	PHARMACY VALUE ALLIANCE, LLC	b875d5f8-02f3-4474-9fda-83091bc7de04	2024-10-28	Warnings	Exact identifier application number: M007
Premier Value Fiber Therapy Original Coarse	PSYLLIUM HUSK	PHARMACY VALUE ALLIANCE, LLC	8c85a13d-ae99-4599-9a28-c3965caa6376	2024-10-28	Warnings	Exact identifier application number: M007
Premier Value	CALCIUM POLYCARBOPHIL	PHARMACY VALUE ALLIANCE, LLC	4d766548-00d0-41bd-bb58-b69e037c77e2	2024-10-28	Warnings	Exact identifier application number: M007
Premier Value Fiber	PSYLLIUM HUSK	Chain Drug Consortium, LLC	c507fe4a-1f8e-4780-a2f5-9da6e5922bef	2024-10-28	Warnings	Exact identifier application number: M007
Premier Value Fiber Therapy Orange Flavor	PSYLLIUM HUSK	PHARMACY VALUE ALLIANCE, LLC	85651bd7-e959-4455-a5ed-bd0223ce0563	2024-10-28	Warnings	Exact identifier application number: M007
Stool Softener	DOCUSATE SODIUM AND SENNOSIDES	BETTER LIVING BRANDS LLC.	f2c61c71-9a23-4bd3-e053-2a95a90ad460	2024-10-26	Warnings	Exact identifier application number: M007
Pedia-Lax	GLYCERIN	C.B. Fleet Company, Inc.	ae367381-7146-4307-823d-2bb44c1d4200	2024-10-25	Warnings	Exact identifier application number: M007
Epsom Salt	MAGNESIUM SULFATE	Target Corporation	f7309f4a-f1f5-420e-bfc7-fb4495a5afba	2024-10-24	Warnings	Exact identifier application number: M007
Epsom Salt	MAGNESIUM SULFATE	Target Corporation	2540ae39-2218-0f6a-e063-6294a90a5efc	2024-10-24	Warnings	Exact identifier application number: M007
DOCUSATE SODIUM	DOCUSATE SODIUM	Sam's West Inc	b0e99ebb-41fc-459f-86d2-f0e3527f97b0	2024-10-24	Warnings	Exact identifier application number: M007
Stool Softener	DOCUSATE SODIUM	A-S Medication Solutions	ef05ad45-7082-43e6-9533-a79c5aa0f373	2024-10-22	Warnings	Exact identifier application number: M007
Bliss GVS Children	GLYCERIN	Bliss GVS Pharma Limited	03237ed2-265f-4acd-b504-d82b9263287c	2024-10-17	Warnings	Exact identifier application number: M007
NATURAL Epsom Salt	MAGNESIUM SULFATE	Universal Distribution Center LLC	b2682e51-ffa4-4556-b2a6-b0dbd543fd4f	2024-10-16	Warnings	Exact identifier application number: M007
Bliss GVS	GLYCERIN	Bliss GVS Pharma Limited	1a3982a1-9ce9-4a1a-ba73-ebe2d8647109	2024-10-10	Warnings	Exact identifier application number: M007
Bisacodyl	BISACODYL	Padagis US LLC	7eada0fc-5f83-43da-a56f-b0f537298208	2024-10-10	Warnings	Exact identifier application number: M007
exchange select stool softener	DOCUSATE SODIUM	Army & Air Force Exchange Service	14985848-d791-42b9-ad7e-810a85bb1ee1	2024-10-07	Warnings	Exact identifier application number: M007

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
PDC6A3C0OX	GLYCERIN	56-81-5	GLYCERIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
583084	glycerin 2.1 GM Adult Rectal Suppository	PSN	e6a8914f-cfd9-4c72-abaa-22189bf0faef	11
583084	glycerin 2100 MG Rectal Suppository	SCD	e6a8914f-cfd9-4c72-abaa-22189bf0faef	11
583084	glycerin 2.1 GM Rectal Suppository	SY	e6a8914f-cfd9-4c72-abaa-22189bf0faef	11
583084	glycerin 82.5 % Adult Rectal Suppository	SY	e6a8914f-cfd9-4c72-abaa-22189bf0faef	11
583084	glycerin 2.1 GM Adult Rectal Suppository	PSN	89b5d376-f8c6-4c86-9dd8-67d047d0d45b	1
583084	glycerin 2100 MG Rectal Suppository	SCD	89b5d376-f8c6-4c86-9dd8-67d047d0d45b	1
583084	glycerin 2.1 GM Rectal Suppository	SY	89b5d376-f8c6-4c86-9dd8-67d047d0d45b	1
583084	glycerin 82.5 % Adult Rectal Suppository	SY	89b5d376-f8c6-4c86-9dd8-67d047d0d45b	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
46122-221-63	46122022163	25 SUPPOSITORY in 1 JAR (46122-221-63)	25 suppository	2013-09-12	0000-00-00	No	No	Current
46122-221-71	46122022171	50 SUPPOSITORY in 1 JAR (46122-221-71)	50 suppository	2013-09-12	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Glycerin	Amerisource Bergen/Good Neighbor Pharmacy \| DSC Laboratories Inc.	2025-10-16	HUMAN OTC DRUG LABEL	11
Glycerin	ATLANTIC BIOLOGICALS CORP.	2018-12-19	HUMAN OTC DRUG LABEL	1